Trial Details
COMPLETEDBasic Information
| Clinical ID | c2396 |
|---|---|
| Identifier | NCT03555617 |
| Trial Title | Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Disease |
| Interventions | DRUG: TD-1473|DRUG: Itraconazole |
Participant Information
| Sponsor | Theravance Biopharma |
|---|---|
| City | Lincoln |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-06-13 |
|---|---|
| Primary Completion Date | 2018-07-15 |
| Completion Date | 2018-07-15 |